The Specialist Forum Volume 13 No 11 November 2013 | Page 12

HIV/AIDS Survival curves on ARTs still improving Dr David Spencer, head of the Adult Antiretroviral Programme, Right to Care T wenty years ago, 25%-35% of South African infants born to infected mothers became HIV positive. That rate has dropped to 2%-5%. Life expectancy has increased. Survival curves on antiretrovirals (ARTs) in the developed world now approximate the uninfected. Survival in the developing world is improving. Local researchers estimate that a South African woman at 20 years with a baseline CD4 ?200c/mm3 and on ART therapy can anticipate an additional 43.1 years (95% CI 40-1-46.0) of survival (Johnson et al). ART reduces transmission. Approximately 96% of uninfected partners of infected persons remain HIV negative when their infected partner takes medication reliably (Cohen et al). When large numbers in a community do so, the ‘community viral load’ falls, as does the spread of the virus in that community. ART treatment becomes prevention. South African researchers have confirmed a significant reduction in community viral load in Cape Town and Johannesburg from 2004-2010 (Carmona et al). Fifteen years ago, the daily ARV pill burden exceeded 20 tablets. Fixed-dose-combination (FDC) tablets now promise control with just one pill a day. Fixed-dose combination ART The first available fixed-dose, once-a-day combination has been atripla. This three-in-one pill incorporates two nucleoside reverse transcriptase inhibitors (NRTIs) and one non-NRTI (NNRTI), namely tenfovir (TDF)+ emtricitabine (FTC)+efavirenz (EFV). It was registered in the US in 2006 and entered the South African market in 2009. Three generic equivalents are Table 1: The Advantages and Disadvantages of Fixed-Dose Antiretroviral Combination Therapy. (Courtesy of the SA Department of Health, 2013) Advantages of FDC ART Disadvantages of FDC ART Grea ???????????????)???????????????????)?????????()??????????????????????????)?????????????????????????????)?????????()????????????????)??????()???????????????????????????)???????????????????????????????)???????????????????????????????()?????????????)???????????????????????)????????????????()X???????????????????????)????????????????????????????????)???????????????99IQ$??????????)?????????()??????????????????)??????????????????)??????????a????d?????????)????????()Q??????????????????????)??????????????????????????(??????????????????????????????)?????????????????????????????? )?????????????????????????????() ?????????????9??????)!????? ?????Q????????) ???????????H?????)????????????????()??????????????????????????????????????????????????????????)????!%X??????????????????)Q?????????????????????????????????????????????H????????????)???????????????????????????????!??????? ????????????????)??????????????????????????]?????????????????????????????????????????????????????????????????]???????????????????????????)?????????????????????????????????????????????????????]???????)???????????????????????????????????????????????????Q????????????)Q???? ????????????????????????????????????????????????)9??????????????????????????????IP??????????????????)Q?????????????????????????????????????????????????????)?????????????????? ????????????????????a??????????d????)????????????????????????????????????????Q????#?e??????????)??????????????????????????????????????????????????)???????????????A??????????????????????????????????????????????()%YH??????????????????????????!%X???????????)M???????????????????????????????????????????????????%YI???)????????????!%X?????????????????????????????????????????)Q?????????????????????????????????????????????????????????QX?????????????????????????????????????????????=??)?????????????????????????????????????????????????????)??????????????????????????????????????????????????????????)?????????????????UL???????????????????????????????????)??????????????????????????????????????????????????????)%YH??????????????????Q?????????????)Q??????????????????????????????%YH?????????????)???????!%X??????????????????????????????????????????Q???)?????????????????????????????%YH??????????Q???????????)??????????????????????????!%X????????????????????????)%YI???????????????????????????????????????????????)???????????????????????????????????????????????????????)???????????????????????????????????????????????????)A??????????????????????QX????????????????????????(???????????????!%X??????????????????????????????????????)?????????????!%X??M!%X??????????????????????????????????)?????????????????????????????????????????????!????)?????????????????????????????????????????????????????????)??????????????????1????????????????????????????????????????)??????????)Q???????????????????????????????????????????????)?????????????????????????????????????????????????Q????????)????????????%YH????????????????????????????????????????????Q???????????????????????????????????????????)%YH???????????????????????????????????????????????) ???????M????)4??I??????H??Q?????IL??M???????@??5??????A54?)9???????T??5?9???????)4??!??????I4?????? P??5?????4??!????? ?)-???A??%????????????????????????????????????????????????????????????????????????????????????????!%X???????????)A???????????????9???????????????M????????????()A??????$$$$$$$$$$()9????????????Q???M????????????((0